Cryonics Revival Scenarios & Potential Roadmaps & Hypotheses

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Priscilla Chan

Published in Artificial Intelligence, Biology, Drugs development & discovery, Organisations, People, Tools.

Priscilla Chan

I spent years at UCSF seeing children with diseases that had no treatment. The question I always wanted answered wasn’t general—it was specific to the patient in front of me.

Given this child’s genome, these symptoms, this cell type: what is the molecular failure? Which pathway is downstream? If we have five possible therapeutic strategies, which one is biologically plausible enough to test first?

Medicine often treats depression or hypertension like a single condition. The reality is they’re dozens of different diseases—maybe hundreds. Each with unique molecular origins. And if we’re going to help each person, we need to be able to see and understand those differences much more clearly than we can today.

That belief is what led Mark and me to build Biohub. And it’s why I find this moment so meaningful.

I joined Alex Rives and Mark on No Priors to talk about what AI makes possible for patients—and why I believe real precision medicine is closer than most people think. https://lnkd.in/gBmhPzzj